These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2742829)

  • 1. DNA repair in cells sensitive and resistant to cis-diamminedichloroplatinum(II): host cell reactivation of damaged plasmid DNA.
    Sheibani N; Jennerwein MM; Eastman A
    Biochemistry; 1989 Apr; 28(7):3120-4. PubMed ID: 2742829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of DNA repair in resistance of L1210 cells to isomeric 1,2-diaminocyclohexaneplatinum complexes and ultraviolet irradiation.
    Jennerwein MM; Eastman A; Khokhar AR
    Mutat Res; 1991 Jan; 254(1):89-96. PubMed ID: 1986276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced repair of a cisplatin-damaged reporter chloramphenicol-O-acetyltransferase gene and altered activities of DNA polymerases alpha and beta, and DNA ligase in cells of a human malignant glioma following in vivo cisplatin therapy.
    Ali-Osman F; Berger MS; Rairkar A; Stein DE
    J Cell Biochem; 1994 Jan; 54(1):11-9. PubMed ID: 8126081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced host cell reactivation of damaged plasmid DNA in HeLa cells resistant to cis-diamminedichloroplatinum(II).
    Chao CC; Lee YL; Cheng PW; Lin-Chao S
    Cancer Res; 1991 Jan; 51(2):601-5. PubMed ID: 1898714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host cell reactivation of cisplatin-damaged plasmid DNA in human non-T leukocyte cell lines.
    Dabholkar M; Reed E
    Cancer Lett; 1992 Apr; 63(2):143-50. PubMed ID: 1314131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host-cell reactivation of cisplatin-damaged pRSVcat in a human lymphoid cell line.
    Dabholkar M; Eastman A; Reed E
    Carcinogenesis; 1990 Oct; 11(10):1761-4. PubMed ID: 2170046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of cis-diamminedichloroplatinum(II) on DNA synthesis and cell cycle progression in excision repair proficient and deficient Chinese hamster ovary cells.
    Sorenson CM; Eastman A
    Cancer Res; 1988 Dec; 48(23):6703-7. PubMed ID: 3180081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repair of plasmid DNA damaged in vitro with cis- or trans-diamminedichloroplatinum(II) in Escherichia coli.
    Popoff SC; Beck DJ; Rupp WD
    Mutat Res; 1987 Mar; 183(2):129-37. PubMed ID: 3547106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The significance of DNA cross-linking to cis-diamminedichloroplatinum(II)-induced cytotoxicity in sensitive and resistant lines of murine leukemia L1210 cells.
    Strandberg MC; Bresnick E; Eastman A
    Chem Biol Interact; 1982 Mar; 39(2):169-80. PubMed ID: 7199396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II).
    Eastman A; Schulte N
    Biochemistry; 1988 Jun; 27(13):4730-4. PubMed ID: 3167012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA excision-repair synthesis is enhanced in a murine leukemia L1210 cell line resistant to cisplatin.
    Calsou P; Barret JM; Cros S; Salles B
    Eur J Biochem; 1993 Feb; 211(3):403-9. PubMed ID: 8436104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repair synthesis by human cell extracts in cisplatin-damaged DNA is preferentially determined by minor adducts.
    Calsou P; Frit P; Salles B
    Nucleic Acids Res; 1992 Dec; 20(23):6363-8. PubMed ID: 1475197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between cell killing by cis-diamminedichloroplatinum(II) in six mammalian cell lines and binding of a cis-diamminedichloroplatinum(II)-DNA antiserum.
    Terheggen PM; Emondt JY; Floot BG; Dijkman R; Schrier PI; den Engelse L; Begg AC
    Cancer Res; 1990 Jun; 50(12):3556-61. PubMed ID: 2340504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA-protein cross-linking in L1210 cells sensitive and resistant to cis-diamminedichloroplatinum (II).
    Olinski R; Briggs RC
    Mol Biol Rep; 1991 May; 15(2):81-6. PubMed ID: 1749377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA adducts of cis-diamminedichloroplatinum(II) and its trans isomer inhibit RNA polymerase II differentially in vivo.
    Mello JA; Lippard SJ; Essigmann JM
    Biochemistry; 1995 Nov; 34(45):14783-91. PubMed ID: 7578087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple mechanisms of resistance to cis-diamminedichloroplatinum(II) in murine leukemia L1210 cells.
    Richon VM; Schulte N; Eastman A
    Cancer Res; 1987 Apr; 47(8):2056-61. PubMed ID: 3828995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic reversion of cisplatin resistance in human cells accompanies reduced host cell reactivation of damaged plasmid.
    Chao CC; Lee YL; Lin-Chao S
    Biochem Biophys Res Commun; 1990 Jul; 170(2):851-9. PubMed ID: 2116798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential uptake of cis-diamminedichloroplatinum (II) by sensitive and resistant murine L1210 leukemia cells.
    Waud WR
    Cancer Res; 1987 Dec; 47(24 Pt 1):6549-55. PubMed ID: 3677093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrum of cis-diamminedichloroplatinum(II)-induced mutations in a shuttle vector propagated in human cells.
    Bubley GJ; Ashburner BP; Teicher BA
    Mol Carcinog; 1991; 4(5):397-406. PubMed ID: 1910483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quenching of DNA:platinum(II) monoadducts as a possible mechanism of resistance to cis-diamminedichloroplatinum(II) in L1210 cells.
    Micetich K; Zwelling LA; Kohn KW
    Cancer Res; 1983 Aug; 43(8):3609-13. PubMed ID: 6683124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.